Pancreatic Cancer Research at TGen Gets $18 Million Infusion

How bad is pancreatic cancer? Ninety percent of people who find out they have it die within a year. And the pancreas isn't even a brand-name digestive organ, like the kidney or liver.

The ghastly statistic is one reason the gene-science gurus at TGen in Phoenix are major recipients in $74 million of gifts being distributed nationwide by the Stand Up to Cancer foundation. TGen's getting $18 million.

What's great about this foundation is the aim to put research into practice -- and make patients well -- ASAP. The research conducted by TGen with its share of the gifts will be tried out at Scottsdale Healthcare at Shea hospital.

TGen says its role will be to:

...launch a series of innovative clinical trials in advanced pancreatic cancer. These clinical trials will be designed to deprive pancreatic tumors of crucial nutrients, thereby cutting off the fuel supply.

Sounds like a plan.

KEEP PHOENIX NEW TIMES FREE... Since we started Phoenix New Times, it has been defined as the free, independent voice of Phoenix, and we'd like to keep it that way. With local media under siege, it's more important than ever for us to rally support behind funding our local journalism. You can help by participating in our "I Support" program, allowing us to keep offering readers access to our incisive coverage of local news, food and culture with no paywalls.
Ray Stern has worked as a newspaper reporter in Arizona for more than two decades. He's won numerous awards for his reporting, including the Arizona Press Club's Don Bolles Award for Investigative Journalism.
Contact: Ray Stern